LONDON, Nov. 16 (Xinhua) -- British pharmacy chain Boots has launched a doctor-led medical cannabis for eligible patients aged 25 and older, British media reported on Monday.
The reports described it as the first such service offered by a British high street pharmacy. The service, called SureLeaf, is intended for people with eligible chronic pain conditions, generalized anxiety disorder or insomnia.
Patients can begin the assessment process online. A clinical team will review their suitability, and those deemed eligible will be invited to attend a video consultation with a consultant.
Medical cannabis has been legal for prescription in Britain since 2018 for the management of symptoms associated with certain diagnosed conditions.
Boots said medical cannabis, when used as prescribed by a clinician, carried a lower risk of addiction than many commonly prescribed pain medications. ■
